[(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate

C46H80O14P2 — CID 156978842

IUPAC[(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate
SMILESCC/C=C\CC(O)/C=C/C=C/C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)O)OC(=O)CCCCCCCCCCCCCCC(C)C
InChIInChI=1S/C46H80O14P2/c1-4-5-27-33-42(47)34-29-24-20-16-12-7-6-8-13-17-21-25-30-35-45(49)56-39-44(40-59-62(54,55)58-38-43(48)37-57-61(51,52)53)60-46(50)36-31-26-22-18-14-10-9-11-15-19-23-28-32-41(2)3/h5,7-8,12-13,20-21,24-25,27,29,34,41-44,47-48H,4,6,9-11,14-19,22-23,26,28,30-33,35-40H2,1-3H3,(H,54,55)(H2,51,52,53)/b12-7-,13-8-,24-20+,25-21-,27-5-,34-29+/t42?,43-,44+/m0/s1
InChIKeyPFDQNKHPCMYLBT-NZPUTYMLSA-N
MW919.08 g/mol
LogP10.61
Rot. Bonds41

About [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate

[(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate (PubChem CID 156978842) has the molecular formula C46H80O14P2 and a molecular weight of 919.08 g/mol. Its IUPAC name is [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate.

Molecular Properties

Compound Name[(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate
PubChem CID156978842
Molecular FormulaC46H80O14P2
Molecular Weight919.08 g/mol
Exact Mass918.50
IUPAC Name[(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate
SMILESCC/C=C\CC(O)/C=C/C=C/C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)O)OC(=O)CCCCCCCCCCCCCCC(C)C
InChIInChI=1S/C46H80O14P2/c1-4-5-27-33-42(47)34-29-24-20-16-12-7-6-8-13-17-21-25-30-35-45(49)56-39-44(40-59-62(54,55)58-38-43(48)37-57-61(51,52)53)60-46(50)36-31-26-22-18-14-10-9-11-15-19-23-28-32-41(2)3/h5,7-8,12-13,20-21,24-25,27,29,34,41-44,47-48H,4,6,9-11,14-19,22-23,26,28,30-33,35-40H2,1-3H3,(H,54,55)(H2,51,52,53)/b12-7-,13-8-,24-20+,25-21-,27-5-,34-29+/t42?,43-,44+/m0/s1
InChIKeyPFDQNKHPCMYLBT-NZPUTYMLSA-N
XLogP10.61
TPSA215.58 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds41
Heavy Atoms62
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500919.08
LogP ≤ 510.61
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate?
The IUPAC name of [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate (CID 156978842) is [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate.
What is the SMILES notation for [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate?
The canonical SMILES for [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate is CC/C=C\CC(O)/C=C/C=C/C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)O)OC(=O)CCCCCCCCCCCCCCC(C)C.
What is the InChIKey of [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate?
The InChIKey is PFDQNKHPCMYLBT-NZPUTYMLSA-N. The full InChI is InChI=1S/C46H80O14P2/c1-4-5-27-33-42(47)34-29-24-20-16-12-7-6-8-13-17-21-25-30-35-45(49)56-39-44(40-59-62(54,55)58-38-43(48)37-57-61(51,52)53)60-46(50)36-31-26-22-18-14-10-9-11-15-19-23-28-32-41(2)3/h5,7-8,12-13,20-21,24-25,27,29,34,41-44,47-48H,4,6,9-11,14-19,22-23,26,28,30-33,35-40H2,1-3H3,(H,54,55)(H2,51,52,53)/b12-7-,13-8-,24-20+,25-21-,27-5-,34-29+/t42?,43-,44+/m0/s1.
What are the key properties of [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate?
[(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate has a molecular weight of 919.08 g/mol, XLogP of 10.61, 41 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R)-3-[hydroxy-[(2S)-2-hydroxy-3-phosphonooxypropoxy]phosphoryl]oxy-2-(16-methylheptadecanoyloxy)propyl] (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoate is sourced from PubChem (CID 156978842), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).